Please login to the form below

MRC

This page shows the latest MRC news and features for those working in and with pharma, biotech and healthcare.

UK immunology biotech MiroBio launches with $34m fundraising

The new company has been set up to draw on discoveries made at the laboratories of Simon Davis, professor of molecular immunology at the MRC Weatherall Institute of Molecular Medicine, and

Latest news

LifeArc takes $30m equity stake in Kymab, gains access to antibody tech

This is thanks to LifeArc’s work (then known as MRC Technology) in humanising the mouse antibody on which Keytruda was based – thus the new Kymab collaboration is building on this
Novartis forges AI alliance with Oxford University

The alliance also brings in other partners, including the Medical Research Council (MRC) Harwell Institute – which will carry out data ‘wrangling’, i.e.
Gilead and Aelix join forces to pursue HIV ‘cure’

Other groups are also working on eradication strategies, including an academic consortium led by Imperial College London, the University of Oxford, MRC Clinical Trials Unit at UCL, and the University of
Three share Nobel chemistry prize for work on protein ‘evolution’

Meanwhile, the Medical Research Council (MRC) – where Sir Gregory was formerly deputy director – also praised the recipients, saying that the phage display work “initiated a pharmaceutical revolution and led to the
Daily Brief: Jazz Pharma and Ultragenyx approvals, Autonomous AI in retinopathy

Jazz Pharmaceuticals has gained EU approval for Vyxeos, its treatment for adults with newly diagnosed, therapy-related acute myeloid leukaemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC). ... MRC, a rapidly progressing and

More from news
Approximately 12 fully matching, plus 39 partially matching documents found.

Latest Intelligence

AstraZeneca: building a new ‘open innovation’ pharma company

MRC scientists are welcome to work in the building and our oncology staff are working in the CRUK Institute.
30 Women Leaders in UK Healthcare (part 3)

26. Professor Janet Darbyshire, Emeritus Professor of Epidemiology, University College London, Honorary Senior Scientist, MRC Clinical Trials Unit. ... She established the MRC Clinical Trials Unit (CTU) at UCL as an internationally recognised centre of
30 Women Leaders in UK Healthcare (part 2)

20. Prof Rebecca Fitzgerald, MRC Cancer Unit, University of Cambridge, and Honorary Consultant in Gastroenterology, Cambridge University NHS Hospitals Foundation Trust.
Pharma deals during July 2014

As part of the collaborative spirit, the UK's Medical Research Council (MRC) announced this month that it has entered into an arrangement under which seven leading pharma companies (AZ, GSK, ... J&J, Lilly, Pfizer, Takeda and UCB) have agreed to make
Pharma deals during March 2014

Under the five-year agreement, scientists from the MRC will work closely with AZ's scientists to identify drug targets and screen promising candidates. ... MRC scientists will have access to AZ's vast compound library and will use high-throughput

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

EM Imaging appoints new chairman

Jeans also chairs the board of UK Biocentre, and has sat on advisory panels for the MRC, EPSRC, NIHR and the Wellcome Trust. .
MRC Technology appoints director of technology transfer

Andrew Farquharson will join the firm from September 1. MRC Technology has named Andrew Farquharson as director of technology transfer, effective from September 1. ... Dr Dave Tapolczay, CEO at MRC Technology, added: “Andrew's extensive experience will
MRC Technology names finance director

Andrew Mercieca took up the role on April 1. Independent life science medical research charity MRC Technology has named Andrew Mercieca as its finance director. ... Dave Tapolczay, CEO at MRC Technology, added: “Andrew has been a great asset to the
Medical Research Council selects Royal Mail’s Donald Brydon as new chair

The UK's Medical Research Council (MRC) has appointed Donald Brydon from the Royal Mail Group as its new chair. ... He will take over from John Chisholm in October at the MRC, a publicly-funded organisation focused on healthcare research.

More from appointments
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Account director: Competitive salary and bonus scheme

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Brand Manager - Medium Global Pharma Company: £Competitive Financial Package

Senior External Communications Lead: £Competitive Salary

Account Manager: £Competitive Salary

Senior Medical Writer or Lead Medical Writer: £Competitive Salary

Senior Medical Writer, MedComms Agency: Salary TBC

Account Manager (PR): Great Benefits

Scientific Director: £60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more

Publications director: Competitive salary and bonus scheme

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Group Director of Medical Affairs and Scientific Strategy, Medic...: Substantial six figure package

Digital Associate Director - Medcomms: £65000 - £80000 per annum

Account Director, Healthcare Communications: Salary TBC

Account Director: £Competitive Salary

Experienced medical editor: Competitive salary and bonus scheme

Account Director, Medical Education: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Novo Nordisk awakens its ‘Sleeping Beauty’: Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?: Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019: OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...